M RN4 Pill - blue round
Pill with imprint M RN4 is Blue, Round and has been identified as Risperidone (Orally Disintegrating) 4 mg. It is supplied by Mylan Pharmaceuticals Inc.
Risperidone is used in the treatment of Autism; Asperger Syndrome; Bipolar Disorder; Schizoaffective Disorder; Schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Risperidone 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M RN4
Risperidone (Orally Disintegrating)
- Imprint
- M RN4
- Strength
- 4 mg
- Color
- Blue
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-6047 (Discontinued)
- Inactive Ingredients
-
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer,
aspartame,
FD&C Blue No. 1,
FD&C Yellow No. 6,
magnesium stearate,
mannitol,
lactose monohydrate,
silicon dioxide,
sodium lauryl sulfate,
sodium stearyl fumarate,
sorbitol,
stearic acid
Note: Inactive ingredients may vary.
Related images for "M RN4"
More about risperidone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (722)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: atypical antipsychotics
- Breastfeeding
Patient resources
- Risperidone drug information
- Risperidone injection
- Risperidone (Intramuscular, Subcutaneous) (Advanced Reading)
- Risperidone Orally Disintegrating Tablets
Other brands
Risperdal, Uzedy, Risperdal Consta, Perseris, ... +2 more
Professional resources
- Risperidone monograph
- Risperidone (FDA)
- Risperidone Oral Solution (FDA)
- Risperidone Orally Disintegrating (FDA)
Other brands
Risperdal, Uzedy, Risperdal Consta, Perseris, Rykindo
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.